🇺🇸 FDA
Patent

US 10105316

Inhalation compositions comprising muscarinic receptor antagonist

granted A61KA61K31/137A61K31/138

Quick answer

US patent 10105316 (Inhalation compositions comprising muscarinic receptor antagonist) held by ARVEN ILAC SANAYI VE TICARET A.S. expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARVEN ILAC SANAYI VE TICARET A.S.
Grant date
Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/137, A61K31/138, A61K31/167, A61K31/24